首页> 外文OA文献 >Amoxicillin Loaded Chitosan–Alginate Polyelectrolyte Complex Nanoparticles as Mucopenetrating Delivery System for H. Pylori
【2h】

Amoxicillin Loaded Chitosan–Alginate Polyelectrolyte Complex Nanoparticles as Mucopenetrating Delivery System for H. Pylori

机译:阿莫西林负载壳聚糖-海藻酸酯聚电解质复合物纳米颗粒作为幽门螺杆菌的粘膜渗透递送系统。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study has been undertaken to apply the concept of nanoparticulate mucopenetrating drug delivery system for complete eradication of Helicobacter pylori (H. pylori), colonised deep into the gastric mucosal lining. Most of the existing drug delivery systems have failed on account of either improper mucoadhesion or mucopenetration and no dosage form with dual activity of adhesion and penetration has been designed till date for treating H. pylori induced disorders. In the present study, novel chitosan-alginate polyelectrolyte complex (CS-ALG PEC) nanoparticles of amoxicillin have been designed and optimized for various variables such as pH and mixing ratio of polymers, concentrations of polymers, drug and surfactant, using 33 Box-Behnken design. Various studies like particle size, surface charge, percent drug entrapment, in-vitro mucoadhesion and in-vivo mucopenetration of nanoparticles on rat models were conducted. The optimised FITC labelled CS-ALG PEC nanoparticles have shown comparative low in-vitro mucoadhesion with respect to plain chitosan nanoparticles, but excellent mucopenetration and localization as observed with increased fluorescence in gastric mucosa continuously over 6 hours, which clinically can help in eradication of H. pylori.
机译:已经进行了本研究,以应用纳米颗粒粘膜穿透药物递送系统的概念来完全根除深入胃粘膜内膜的幽门螺杆菌(H. pylori)。由于不适当的粘膜粘附或粘膜渗透,大多数现有的药物输送系统都失败了,迄今为止,尚未设计出具有粘附和渗透双重活性的剂型来治疗幽门螺旋杆菌引起的疾病。在本研究中,使用33 Box-Behnken设计和优化了阿莫西林的新型壳聚糖-海藻酸酯聚电解质复合物(CS-ALG PEC)纳米颗粒,以优化各种变量,例如pH和聚合物的混合比,聚合物的浓度,药物和表面活性剂。设计。在大鼠模型上进行了各种研究,例如纳米颗粒的粒径,表面电荷,药物截留率,体外粘膜粘附和体内粘膜渗透。经过优化的FITC标记的CS-ALG PEC纳米颗粒相对于普通壳聚糖纳米颗粒显示出较低的体外粘膜粘附性,但是优异的粘膜渗透性和定位性(在胃粘膜中连续6小时观察到荧光增强)可在临床上帮助消除H幽门螺杆菌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号